EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of NA ‐1 on Pericyte‐Driven Vasoconstriction and Its Role in No‐Reflow During Cerebral Ischemia–Reperfusion

Xinxuan Yang iD, Jiahui Zhao, Hao Tian, Ximing Nie, Lina Zheng, Xin Liu, Zheng Z Wei, Yuchuan Ding, Liping Liu

CNS Neuroscience & Therapeutics · 2025-05 · 31 (5)

DOI: 10.1111/cns.70409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 25.05.2025. Verfasst von Xinxuan Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Pericytes, Vasoconstriction, Reperfusion Injury, Brain Ischemia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Physician Scientist Training Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The no‐reflow phenomenon in the ischemic brain following arterial recanalization leads to poor prognosis. Previous studies suggest that the clinically proven NA‐1 drug, with disruption of PSD95 in the neuronal terminals alongside the cerebral microvasculature, may inhibit pericytic contraction of microvessels by reducing endothelin‐1 secretion.

Methods

A 1.5‐h tMCAO model using Balb/c mice was employed. In vivo two‐photon imaging and immunofluorescence staining were employed to assess the constriction effect of pericytes on capillaries. The impact of NR2B9c/NA‐1 administration (intravenously infused at a dose of 10 μmol/kg) on pericyte constriction was evaluated through immunofluorescent staining of brain sections. Additionally, The effect of NA‐1 on cerebral perfusion was assessed using laser speckle blood flow monitoring, whole brain slice perfusion, and high‐magnification capillary imaging. Enzyme‐linked immunosorbent Assay (ELISA) was conducted to determine changes in quantitative ONOO − and endothelin‐1 (ET‐1) content after tat‐NA‐1 administration. Lastly, microtubule‐associated protein 2 (MAP2) staining and behavioral scores were used to evaluate the effects of NA‐1 on infarct size and behavioral deficits.

Results

In vivo two‐photon imaging and immunofluorescence staining revealed that pericyte constriction following ischemia and recanalization resulted in a decreased diameter of capillaries, particularly at the soma and adjacent areas. Notably, capillary obstruction was localized near pericytes. After administration of NA‐1, the immunofluorescence staining section showed that the diameter of capillaries at pericytes' soma and in the adjacent parts increased. The ELISA results indicated a reduction in ONOO − and ET‐1 levels. Additionally, MAP2 staining revealed a decrease in infarct size, while behavioral scores showed improvements in deficits. This effect of NA‐1 was counteracted notably when added ET‐1.

Conclusion

NA‐1 inhibits pericyte constriction following ischemia–reperfusion by reducing ET‐1 levels. It improves capillary no‐reflow in mice, enhances cerebral perfusion, decreases infarct size, and mitigates behavioral deficits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericytesVasoconstrictionReperfusion InjuryBrain IschemiaNo-Reflow PhenomenonAnimalsMiceMaleMice, Inbred BALB CCerebrovascular CirculationEndothelin-1Disease Models, AnimalInfarction, Middle Cerebral Artery

Stichwörter der Autor:innen

NA‐1cerebral reperfusionno‐reflow phenomenonpericytes

Substanzen

Endothelin-1

Autor:innen und Institutionen

  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • China National Clinical Research Center for Neurological Diseases, Beijing, China.
  • Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Wayne State University School of Medicine, Detroit, Michigan, USA.

ORCID-Profile: Xinxuan Yang

Förderung

  • Physician Scientist Training Project
  • National Natural Science Foundation of China

Zitieren

APA

Yang, X., Zhao, J., Tian, H., Nie, X., Zheng, L., Liu, X., Wei, Z. Z., Ding, Y., & Liu, L. (2025). Impact of NA ‐1 on Pericyte‐Driven Vasoconstriction and Its Role in No‐Reflow During Cerebral Ischemia–Reperfusion. CNS Neuroscience & Therapeutics, 31(5). https://doi.org/10.1111/cns.70409

Vancouver

Yang X, Zhao J, Tian H, Nie X, Zheng L, Liu X, et al. Impact of NA ‐1 on Pericyte‐Driven Vasoconstriction and Its Role in No‐Reflow During Cerebral Ischemia–Reperfusion. CNS Neuroscience & Therapeutics. 2025;31(5). doi:10.1111/cns.70409

BibTeX
@article{Yang2025,
  author = {Yang, Xinxuan and Zhao, Jiahui and Tian, Hao and Nie, Ximing and Zheng, Lina and Liu, Xin and Wei, Zheng Z and Ding, Yuchuan and Liu, Liping},
  title = {Impact of NA ‐1 on Pericyte‐Driven Vasoconstriction and Its Role in No‐Reflow During Cerebral Ischemia–Reperfusion},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  volume = {31},
  number = {5},
  doi = {10.1111/cns.70409}
}
Kostenlos starten →